Related Experiment Videos
Improved double-antibody enzyme immunoassay for methotrexate.
Clinical Chemistry
|August 1, 1979
Summary
This study introduces a rapid enzyme immunoassay for methotrexate detection, offering a faster alternative to existing methods. The assay demonstrates high specificity and accuracy, correlating well with radioimmunoassay results.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Immunology
Background:
- Methotrexate measurement is crucial for therapeutic drug monitoring.
- Existing methods for methotrexate quantification can be time-consuming.
- Development of rapid and specific immunoassays is needed.
Purpose of the Study:
- To develop and validate a fast enzyme immunoassay (EIA) for quantifying methotrexate.
- To assess the specificity and accuracy of the developed EIA method.
Main Methods:
- Enzyme immunoassay (EIA) utilizing beta-D-galactosidase conjugated to methotrexate.
- Separation of bound and free labeled drug using a preincubated antibody complex.
- Measurement of enzyme activity with o-nitrophenyl-beta-D-galactopyranoside substrate.
Main Results:
- Assay completion time under 3 hours.
- Standard curve range of 1-10 µg/L methotrexate.
- High specificity for methotrexate against related compounds.
- Intra-assay CV < 5%, Inter-assay CV < 10%.
- Excellent agreement with radioimmunoassay (RIA) results.
Conclusions:
- The developed EIA provides a rapid, specific, and accurate method for methotrexate measurement.
- This assay is suitable for clinical settings requiring timely drug level determination.
- The method offers a viable alternative to traditional radioimmunoassays.